These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8450448)

  • 1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
    Sogabe K; Nirei H; Shoubo M; Nomoto A; Ao S; Notsu Y; Ono T
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1040-6. PubMed ID: 8450448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive inotropic effect and the hydrolysis of phosphoinositide induced by endothelin-3 in rabbit ventricular myocardium: inhibition by a selective antagonist of ET(A) receptors, FR139317.
    Endoh M; Norota I; Yang HT; Fujita S; Takanashi M
    J Pharmacol Exp Ther; 1996 Apr; 277(1):61-70. PubMed ID: 8613968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
    Aramori I; Nirei H; Shoubo M; Sogabe K; Nakamura K; Kojo H; Notsu Y; Ono T; Nakanishi S
    Mol Pharmacol; 1993 Feb; 43(2):127-31. PubMed ID: 8429819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist.
    Hoshino T; Yamauchi R; Kikkawa K; Yabana H; Murata S
    J Pharmacol Exp Ther; 1998 Aug; 286(2):643-9. PubMed ID: 9694915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
    Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine production of endothelin-1 participates in the glucocorticoid-induced Ca2+ influx into vascular smooth muscle cells.
    Kato H; Hayashi T; Koshino Y; Oida K; Kutsumi Y; Nakai T; Miyabo S
    Biochem Biophys Res Commun; 1995 Mar; 208(1):82-8. PubMed ID: 7887969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endothelin receptor A antagonist FR139317 on rats with congestive heart failure.
    Chen XC; Zhang XM; Luo NS; Fang C; Liu YM; Wu W
    Acta Pharmacol Sin; 2001 Oct; 22(10):896-900. PubMed ID: 11749771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of BQ-485, a selective ETA antagonist, on endothelin-mediated vasomotion in rat coronary vascular beds.
    Sakuma I; Asajima H; Fukao M; Tohse N; Tamura M; Kitabatake A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S400-3. PubMed ID: 8587427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
    Opgenorth TJ; Adler AL; Calzadilla SV; Chiou WJ; Dayton BD; Dixon DB; Gehrke LJ; Hernandez L; Magnuson SR; Marsh KC; Novosad EI; Von Geldern TW; Wessale JL; Winn M; Wu-Wong JR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):473-81. PubMed ID: 8632312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
    McMurdo L; Lidbury PS; Thiemermann C; Vane JR
    Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endothelin receptor expression in vascular smooth-muscle cells.
    Yu JC; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S348-50. PubMed ID: 8587411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat.
    Filep JG; Clozel M; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Nov; 113(3):845-52. PubMed ID: 7858876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of type A endothelin receptors in MMQ cells.
    Wu-Wong JR; Chiou W; Magnuson SR; Witte DG; Lin CW
    Mol Pharmacol; 1993 Aug; 44(2):285-91. PubMed ID: 8355666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist.
    Williams DL; Murphy KL; Nolan NA; O'Brien JA; Pettibone DJ; Kivlighn SD; Krause SM; Lis EV; Zingaro GJ; Gabel RA
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1518-26. PubMed ID: 8531124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic role of ETA receptors in the regulation of renal hemodynamics in normal and salt-depleted rats.
    Fujihara CK; De Nucci G; Zatz R
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S466-9. PubMed ID: 8587447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
    Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
    J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat.
    Sun XY; Hedner T; Feng Q; Edvinsson L
    Blood Press; 1992 Aug; 1(2):108-12. PubMed ID: 1366258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETA receptor blockade potentiates the bronchoconstrictor response to ET-1 in the guinea pig airway.
    Polakowski JS; Opgenorth TJ; Pollock DM
    Biochem Biophys Res Commun; 1996 Aug; 225(1):225-31. PubMed ID: 8769122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.